Nizar Y. Al-Hariri

الحساب الرسمي للمعهد الوطني لأبحاث الصحة، والذي يهدف إلى تحقيق رؤية المملكة 2030 من خلال دعم الأبحاث الصحية مركزاً على البحوث الانتقالية والتجارب السريرية. The Official Account of the Saudi National Institute of Health, which aims to realize the Kingdom’s Vision 2030 by supporting health research with the focus on translational research and clinical trials.

Badael, which means ‘alternatives’ in Arabic, is a newly founded company owned by the Public Investment Fund. Badaels primary objective is to improve the quality of life and help curb smoking rates in Saudi Arabia by developing innovative reduced-risk alternatives for smokers.  Badael aims to play a complementary but important role in promoting a smoke-free Saudi Arabia by replacing combustible and other tobacco products, so that smokers and people around them can enjoy the benefits of a healthier lifestyle.

Lifera is a biopharmaceutical company wholly owned by the Public Investment Fund (PIF) with a mission to enable two national priority objectives, which are improving Saudi Arabia’s biopharma resilience, and enabling the achievement of the National Biotech Strategy. To achieve this mission, Lifera aims to become a leading biopharma Contract Development and Manufacturing Organization (CDMO) with a focus on advanced therapeutics and critical medicines. Lifera’s strategy is to be a service provider to biopharma and biotech companies globally by developing and acquiring state-of-the-art cGMP biomanufacturing capacity, establishing high throughput multi-omics capacity to support clinical, population health and R&D customers, securing high-value commercial partnerships and technology transfer, and developing a high caliber biopharma workforce. Lifera serves customers for both KSA and global markets through contract manufacturing of biologics including insulin, vaccines, monoclonal antibodies, gene therapies, and other advanced medicinal products, as well as through genetic testing services with a global presence and depth in rare disease with plans to expand into other therapeutic areas.

Established in 2009, King Abdullah University of Science and Technology (KAUST) is a graduate-level research university located on the shores of the Red Sea in Saudi Arabia. KAUST is dedicated to advancing science and technology through interdisciplinary research, education and innovation. Curiosity-driven and goal-oriented research is conducted by students, faculty, scientists and engineers to address the world’s pressing scientific and technological challenges related to food, water, energy and the environment. The University currently educates and trains over 900 master’s and doctoral students supported by an academic community of 150 faculty members, 400 postdocs and 300 research scientists. With 100 nationalities working and living at KAUST, the University brings together people and ideas from all over the world. For more information visit www.kaust.edu.sa

برنامج تطوير الصناعة الوطنية والخدمات اللوجستية (ندلب) من أهم برامج رؤية المملكة 2030. يسعى البرنامج إلى تحويل المملكة العربية السعودية إلى قوة صناعية رائدة ومنصة لوجستية عالمية عبر تحقيق التكامل بين قطاعات النمو الواعدة (الصناعة، والتعدين والطاقة، والخدمات اللوجستية) وتحفيز الاستثمار في هذه القطاعات ورفع مساهمة القطاع الخاص بهدف تحقيق التنوع الاقتصادي وخلق فرص عمل نوعية للكفاءات الوطنية الواعدة، وتحسين الموازين التجارية للمملكة وتعظيم مساهمة المحتوى المحلي. المستهدفات الرئيسية بحلول عام 2030 • 1.7 تريليون ريال تحفيز استثمارات القطاع الخاص • 1.2 تريليون ريال زيادة اجمالي الناتج المحلي • 1.6 مليون وظيفة جديدة • زيادة التصدير وإعادة التصدير ليصل إلى أكثر من 1 تريليون ريال سعودي The National Industrial Development and Logistics Program (NIDLP) is one of 13 programs aiming to achieve Saudi Arabia’s 2030 Vision. The program focuses on transforming the Kingdom of Saudi Arabia into a leading industrial powerhouse and a global logistics hub in promising growth sectors including Industry, Mining, Energy and Logistics. By 2030, the program aims to stimulate private sector investments, generating ample job opportunities for Saudis, enhance the Kingdoms trade balance and maximize local content. 2030 key targets • Stimulate private sector investments by $ 453 Bn. • Increase GDP with $ 320 Bn. • Provide 1.6 million new jobs. • Increase export and re-export to more than $ 266 Bn.

CAD’s vision is to become the most preferred and dependable partner worldwide for APIs and CRAMS in the MENA region by 2020. CAD’s mission is to become one of the premier manufacturer of high quality Active Pharmaceutical Ingredients worldwide through Innovation, quality, advanced technology, equipment and meeting the needs of its clients under the guidelines of USFDA, EDQM/EMEA and cGMP in most effective manner.

الحساب الرسمي للمعهد الوطني لأبحاث الصحة، والذي يهدف إلى تحقيق رؤية المملكة 2030 من خلال دعم الأبحاث الصحية مركزاً على البحوث الانتقالية والتجارب السريرية. The Official Account of the Saudi National Institute of Health, which aims to realize the Kingdom’s Vision 2030 by supporting health research with the focus on translational research and clinical trials.

1st University in Saudi Arabia. KSU Mission: To provide students with a quality education, conduct valuable research, serve the national and international societies and contribute to Saudi Arabia’s knowledge society through learning, creativity, the use of current and developing technologies and effective international partnership.

Badael, which means ‘alternatives’ in Arabic, is a newly founded company owned by the Public Investment Fund. Badaels primary objective is to improve the quality of life and help curb smoking rates in Saudi Arabia by developing innovative reduced-risk alternatives for smokers.  Badael aims to play a complementary but important role in promoting a smoke-free Saudi Arabia by replacing combustible and other tobacco products, so that smokers and people around them can enjoy the benefits of a healthier lifestyle.

Lifera is a biopharmaceutical company wholly owned by the Public Investment Fund (PIF) with a mission to enable two national priority objectives, which are improving Saudi Arabia’s biopharma resilience, and enabling the achievement of the National Biotech Strategy. To achieve this mission, Lifera aims to become a leading biopharma Contract Development and Manufacturing Organization (CDMO) with a focus on advanced therapeutics and critical medicines. Lifera’s strategy is to be a service provider to biopharma and biotech companies globally by developing and acquiring state-of-the-art cGMP biomanufacturing capacity, establishing high throughput multi-omics capacity to support clinical, population health and R&D customers, securing high-value commercial partnerships and technology transfer, and developing a high caliber biopharma workforce. Lifera serves customers for both KSA and global markets through contract manufacturing of biologics including insulin, vaccines, monoclonal antibodies, gene therapies, and other advanced medicinal products, as well as through genetic testing services with a global presence and depth in rare disease with plans to expand into other therapeutic areas.

Established in 2009, King Abdullah University of Science and Technology (KAUST) is a graduate-level research university located on the shores of the Red Sea in Saudi Arabia. KAUST is dedicated to advancing science and technology through interdisciplinary research, education and innovation. Curiosity-driven and goal-oriented research is conducted by students, faculty, scientists and engineers to address the world’s pressing scientific and technological challenges related to food, water, energy and the environment. The University currently educates and trains over 900 master’s and doctoral students supported by an academic community of 150 faculty members, 400 postdocs and 300 research scientists. With 100 nationalities working and living at KAUST, the University brings together people and ideas from all over the world. For more information visit www.kaust.edu.sa